Literature DB >> 29286255

miR-106b-responsive gene landscape identifies regulation of Kruppel-like factor family.

Cody J Wehrkamp1, Sathish Kumar Natarajan1, Ashley M Mohr1, Mary Anne Phillippi1, Justin L Mott1.   

Abstract

MicroRNA dysregulation is a common feature of cancer and due to the promiscuity of microRNA binding this can result in a wide array of genes whose expression is altered. miR-106b is an oncomiR overexpressed in cholangiocarcinoma and its upregulation in this and other cancers often leads to repression of anti-tumorigenic targets. The goal of this study was to identify the miR-106b-regulated gene landscape in cholangiocarcinoma cells using a genome-wide, unbiased mRNA analysis. Through RNA-Seq we found 112 mRNAs significantly repressed by miR-106b. The majority of these genes contain the specific miR-106b seed-binding site. We have validated 11 genes from this set at the mRNA level and demonstrated regulation by miR-106b of 7 proteins. Combined analysis of our miR-106b-regulated mRNA data set plus published reports indicate that miR-106b binding is anchored by G:C pairing in and near the seed. Novel targets Kruppel-like factor 2 (KLF2) and KLF6 were verified both at the mRNA and at the protein level. Further investigation showed regulation of four other KLF family members by miR-106b. We have discovered coordinated repression of multiple members of the KLF family by miR-106b that may play a role in cholangiocarcinoma tumor biology.

Entities:  

Keywords:  Apoptosis; KLF10; KLF11; KLF13; KLF2; KLF4; KLF6; LKLF; biliary tract cancer; lung Kruppel-like factor; miR-106a; miRNA; next-generation sequencing

Mesh:

Substances:

Year:  2018        PMID: 29286255      PMCID: PMC5927729          DOI: 10.1080/15476286.2017.1422471

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  51 in total

1.  Functional microRNA targets in protein coding sequences.

Authors:  Martin Reczko; Manolis Maragkakis; Panagiotis Alexiou; Ivo Grosse; Artemis G Hatzigeorgiou
Journal:  Bioinformatics       Date:  2012-01-27       Impact factor: 6.937

2.  Opposing regulation of BIM and BCL2 controls glucocorticoid-induced apoptosis of pediatric acute lymphoblastic leukemia cells.

Authors:  Duohui Jing; Vivek A Bhadri; Dominik Beck; Julie A I Thoms; Nurul A Yakob; Jason W H Wong; Kathy Knezevic; John E Pimanda; Richard B Lock
Journal:  Blood       Date:  2014-10-21       Impact factor: 22.113

3.  miR-93/106b and their host gene, MCM7, are differentially expressed in leiomyomas and functionally target F3 and IL-8.

Authors:  Tsai-Der Chuang; Xiaoping Luo; Harekrushna Panda; Nasser Chegini
Journal:  Mol Endocrinol       Date:  2012-05-03

4.  Biliary adenocarcinoma. Characterisation of three new human tumor cell lines.

Authors:  A Knuth; H Gabbert; W Dippold; O Klein; W Sachsse; D Bitter-Suermann; W Prellwitz; K H Meyer zum Büschenfelde
Journal:  J Hepatol       Date:  1985       Impact factor: 25.083

5.  MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3.

Authors:  Florin M Selaru; Alexandru V Olaru; Takatsugu Kan; Stefan David; Yulan Cheng; Yuriko Mori; Jian Yang; Bogdan Paun; Zhe Jin; Rachana Agarwal; James P Hamilton; John Abraham; Christos Georgiades; Hector Alvarez; Perumal Vivekanandan; Wayne Yu; Anirban Maitra; Michael Torbenson; Paul J Thuluvath; Gregory J Gores; Nicholas F LaRusso; Ralph Hruban; Stephen J Meltzer
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

6.  Mammalian microRNAs predominantly act to decrease target mRNA levels.

Authors:  Huili Guo; Nicholas T Ingolia; Jonathan S Weissman; David P Bartel
Journal:  Nature       Date:  2010-08-12       Impact factor: 49.962

7.  miR-106b downregulates adenomatous polyposis coli and promotes cell proliferation in human hepatocellular carcinoma.

Authors:  Gang Shen; Hongyun Jia; Qiang Tai; Yanhao Li; Deji Chen
Journal:  Carcinogenesis       Date:  2012-10-20       Impact factor: 4.944

8.  Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding.

Authors:  Aleksandra Helwak; Grzegorz Kudla; Tatiana Dudnakova; David Tollervey
Journal:  Cell       Date:  2013-04-25       Impact factor: 41.582

9.  Silencing of Kruppel-like factor 2 by the histone methyltransferase EZH2 in human cancer.

Authors:  H Taniguchi; F V Jacinto; A Villanueva; A F Fernandez; H Yamamoto; F J Carmona; S Puertas; V E Marquez; Y Shinomura; K Imai; M Esteller
Journal:  Oncogene       Date:  2011-09-05       Impact factor: 9.867

10.  Perk-dependent repression of miR-106b-25 cluster is required for ER stress-induced apoptosis.

Authors:  S Gupta; D E Read; A Deepti; K Cawley; A Gupta; D Oommen; T Verfaillie; S Matus; M A Smith; J L Mott; P Agostinis; C Hetz; A Samali
Journal:  Cell Death Dis       Date:  2012-06-28       Impact factor: 8.469

View more
  4 in total

1.  CNOT3 targets negative cell cycle regulators in non-small cell lung cancer development.

Authors:  Yo-Taro Shirai; Anna Mizutani; Saori Nishijima; Masafumi Horie; Chisato Kikuguchi; Olga Elisseeva; Tadashi Yamamoto
Journal:  Oncogene       Date:  2018-12-10       Impact factor: 9.867

2.  A stress-responsive miRNA regulates BMP signaling to maintain tissue homeostasis.

Authors:  Sromana Mukherjee; Nuria Paricio; Nicholas S Sokol
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-25       Impact factor: 11.205

Review 3.  The Role of miRNA and Related Pathways in Pathophysiology of Uterine Fibroids-From Bench to Bedside.

Authors:  Michał Ciebiera; Marta Włodarczyk; Stanisław Zgliczyński; Tomasz Łoziński; Klaudia Walczak; Artur Czekierdowski
Journal:  Int J Mol Sci       Date:  2020-04-24       Impact factor: 5.923

4.  Bioinformatics Analysis of mRNAs and miRNAs for Identifying Potential Biomarkers in Lung Adenosquamous Carcinoma.

Authors:  Jin Nie; Ling Gong; Zhu Li; Dong Ou; Ling Zhang; Yi Liu; Jianyong Zhang; Daishun Liu
Journal:  Comput Math Methods Med       Date:  2022-03-02       Impact factor: 2.238

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.